Article
New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease.
Bioengineered - 1 Dec 2020
Yuan Wei, Zhang Wei, Zhang Wei, Ruan Zhong-Bao, Zhu Li, Liu Yu, Mi Yuan-Yuan, Zhang Li-Feng
Abstract excerpt
The relationship between Cyclin-Dependent Kinase Inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) variants rs1333049 G/C and rs4977574 A/G and the risk of coronary heart disease is unclear. We conducted an update analysis incorporating odds ratios and 95% confidence intervals to assess the correlation. Furthermore, we used in silico analysis to investigate the genes and proteins that interact with CDKN2B. Fifty...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.